Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SWK Holdings Corporation
SWKH | US
16.51
USD-0.16
-0.96%
SWKH | US
About SWK Holdings Corporation
Sector
Financial Services
Industry
Asset Management
Earnings date
30/06/2024
As of date
20/03/2026
Close
16.51
Open
16.62
High
16.77
Low
16.51
SWK Holdings Corporation a specialty finance company that focuses on the healthcare sector. It operates in two segments Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies including companies in the biotechnology medical device medical diagnostics and related tools animal health and pharmaceutical industries as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition the company engages in the pharmaceutical development formulation and manufacturing and licensing business through the Peptelligence platform. Further it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas Texas.
View LessSWKH | US
Risk
21.1
Sharpe
1.62
Luna's Score
58/100
Recommendation
Hold
Luna says (SWKH | US)
What's Working
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Declining Revenue (< 0%)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
19.0%1 month
21.1%3 months
15.3%6 months
28.4%Returns
Fundamental Ratios
PE
18.02
Fwd. PE
-
Price to book
0.74
Debt to equity
0.11
Debt to assets
0.10
Ent. to EBITDA
13.96
Ent. to rev.
5.67
PEG
-
Other Fundamentals
EBITDA
-
MarketCap
204.09M
MarketCap(USD)
204.09M
Div. yield
-
Op. margin
39.13
Erngs. growth
13.40
Rev. growth
-35.30
Ret. on equity
4.25
Short ratio
4.51
Short perc.
1.50
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.95
Range1M
0.97
Range3M
1.43
Volumes: Market Activity
Rel. volume
1.35
Price X volume
204.62K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 13.96 | - | Cheaper |
| Ent. to Revenue | 5.67 | - | Cheaper |
| PE Ratio | 18.02 | 20.20 | Par |
| Price to Book | 0.74 | 2.63 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 15.30 | - | Lower Risk |
| Debt to Equity | 0.11 | 50.50 | Cheaper |
| Debt to Assets | 0.10 | 44.08 | Cheaper |
| Market Cap | 204.09M | - | Emerging |
